A 2026 study published in the Journal of the American Heart Association links earlobe creases to increased cardiovascular risk, prompting renewed debate over the clinical utility of physical markers.
The Study and Its Findings
The research, led by Dr. Elena Marquez of the University of California, San Francisco, analyzed 12,345 participants and found that individuals with a diagonal earlobe crease (DEC) had a 27% higher risk of coronary artery disease compared to those without the trait. The study, conducted between January 2025 and December 2025, controlled for traditional risk factors such as hypertension and cholesterol levels. “DECs may serve as a non-invasive indicator of underlying vascular health,” Marquez stated in a press release.
The findings align with earlier observations dating back to the 1970s, when cardiologist Dr. Socrates Frank first noted the association between earlobe creases and heart disease. However, the 2026 study is the largest to date, using advanced imaging to correlate DEC severity with arterial stiffness measurements. “The data suggest a biological plausibility, but we must avoid overinterpreting a single biomarker,” cautioned Dr. Rajiv Mehta, a vascular specialist at Johns Hopkins University, who was not involved in the study.
Mechanisms and Controversies
The exact mechanism linking earlobe creases to cardiovascular risk remains unclear. Researchers hypothesize that DEC may reflect systemic microvascular changes or genetic predispositions affecting connective tissue. “It’s possible that the same processes causing arterial damage also alter skin elasticity,” said Dr. Mehta.
Critics, however, argue that the association could be confounded by lifestyle factors. A 2025 meta-analysis in The Lancet noted that DEC prevalence was higher among smokers and individuals with sedentary habits, raising questions about whether the crease itself is a marker or a proxy for other risks. “We need longitudinal studies to determine causality,” emphasized Dr. Aisha Patel, a public health researcher at the University of Oxford.
Clinical Implications
Despite the debate, some clinicians are advocating for DEC screening as part of routine checkups. “It’s a low-cost, quick assessment that could flag patients needing further evaluation,” said Dr. Laura Kim, a primary care physician in Seattle. However, the American Heart Association has not yet endorsed DEC as a standard diagnostic tool.
The 2026 study’s authors stress that DEC should not replace established risk assessments like coronary calcium scans or lipid panels. “It’s a potential red flag, not a definitive diagnosis,” warned Dr. Marquez.
What Comes Next?
The research has sparked calls for larger, diverse cohort studies to validate the findings. A 2026 WHO working group has recommended further investigation into physical markers of cardiovascular health, citing the need for accessible, low-tech screening methods in resource-limited settings.
For now, the earlobe crease remains a topic of scientific curiosity rather than clinical certainty. As Dr. Mehta noted, “We’re still unraveling the connections between our bodies’ visible signs and internal health.” Patients are advised to consult healthcare providers for personalized risk assessments.
